Cancer Care Startup Complement 1 Raises $16 Mn Seed Funding
The platform draws on data from meta-analyses that support the role of behavioural changes in improving cancer outcomes.
Karan Bajaj, co-founder of WhiteHat Jr, has raised $16 million in seed funding for his new healthtech venture, Complement 1.
The US-based cancer care startup integrates personalized, clinically validated lifestyle coaching into cancer treatment plans.
The round was led by Owl Ventures and Blume Ventures, with participation from several other investors.
As per reports, the seed capital will be used to develop and expand the platform further.
Complement 1 provides cancer patients and high-risk individuals with tailored support on nutrition, sleep, stress management, and physical activity through daily, one-on-one sessions with CoActive Coaches.
“Every oncologist will tell you patients need more support incorporating clinically recommended physical activity, nutrition, and mind-body practices. We’ve cracked the code on daily engagement with personalized, compassionate coaching, helping patients make meaningful, lasting improvements during and beyond treatment," said CEO Bajaj.
The cancer care startup claims that its model has demonstrated strong clinical results.
The platform draws on data from meta-analyses that support the role of behavioural changes in improving cancer outcomes.
Complement 1 reports that its users see a 37% reduction in treatment side effects, 18% less pain, and 27% better sleep, along with a user adherence rate above 90%. The company also claims the platform can reduce cancer-related healthcare costs by up to 30% for providers and insurers.
With nearly half of all Americans expected to receive a cancer diagnosis in their lifetime, the company highlights research showing that lifestyle changes can cut cancer recurrence by 35% and reduce mortality by 37%.
